What You Should Know
- Wolters Kluwer Health announced that it has signed a definitive agreement to acquire San Francisco-based clinical decision support company AgileMD for up to $100M, comprising $40M in upfront cash and up to $60M in performance-based deferred consideration.
- AgileMD delivers AI-powered clinical decision support inside electronic health record (EHR) workflows through two flagship offerings: AgileMD Pathways (which operationalizes hospital-specific clinical guidelines for consistent care delivery) and eCART (an FDA 510(k)-cleared real-time clinical surveillance engine designed to predict inpatient deterioration and reduce mortality).
- The acquisition accelerates the workflow integration of UpToDate Expert AI, which has been adopted by more than 2,700 U.S. hospitals and health systems—representing over 95% of U.S. UpToDate Enterprise Edition customers—since launching in September 2025.
Operationalizing Evidence: Pathways and FDA-Cleared Clinical Surveillance
AgileMD brings two core software engines designed to embed clinical intelligence directly into hospital electronic health record workflows. Its Pathways platform operationalizes institution-specific clinical guidelines directly inside the clinician’s native charting and order-entry environment, driving standardized care delivery and continuous outcomes measurement across service lines.
Complementing Pathways is eCART, an FDA-cleared, real-time artificial intelligence clinical surveillance engine engineered to detect subtle physiological deterioration in hospitalized patients hours before acute cardiac or respiratory arrest occurs. By continuously analyzing vital signs, laboratory results, and demographic data streams inside the electronic health record, eCART stratifies patient mortality risk and triggers timely clinical escalation protocols.
Strategic Convergence: Uniting UpToDate Expert AI with Bedside Execution
For Wolters Kluwer, the acquisition serves as a direct distribution and workflow expansion vehicle for UpToDate, its flagship clinical reference platform. Since debuting in September 2025, UpToDate Expert AI has been adopted by more than 2,700 U.S. hospitals and health systems—representing over 95 percent of its domestic Enterprise Edition customer base. Integrating AgileMD enables Wolters Kluwer to move beyond passive clinical search into active, automated workflow orchestration.
“Combined with UpToDate Expert AI and our partnerships, AgileMD will serve as a vital enabler for true UpToDate ubiquity in healthcare – facilitating UpToDate’s expansion into embedded workflows, local guidelines, and new digital health applications,” said Yaw Fellin, Senior Vice President, Wolters Kluwer Clinical Solutions. “With AgileMD, we are well positioned to help healthcare systems provide better patient care and extract more value from their tech investments.”
Acquisition Economics and Disciplined M&A Valuation
The financial terms reflect a disciplined, milestone-driven valuation framework tailored to high-growth clinical artificial intelligence assets. Based on AgileMD’s projected $7 million in year-end 2026 annual recurring revenue, the $40 million upfront outlay represents roughly 5.7 times trailing revenue, while the full $100 million purchase price implies a 14.3 times multiple contingent on commercial execution.
Wolters Kluwer expects the acquisition to achieve a return on invested capital at or above its after-tax weighted average cost of capital of 8 percent within three to five years, while having an immaterial near-term impact on adjusted corporate earnings.
